Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

B of A Securities Maintains Buy on Oculis Holding, Lowers Price Target to $20

Author: Benzinga Newsdesk | June 11, 2024 07:19am
B of A Securities analyst Jason Gerberry maintains Oculis Holding (NASDAQ:OCS) with a Buy and lowers the price target from $21 to $20.

Posted In: OCS